Wendy Barnes has been appointed as the new President and CEO of GoodRx, a prominent drug discount and digital health company. She will officially assume her new role on January 1, following her tenure as the CEO of RxBenefits, a pharmacy benefits optimizer that advises self-insured employers on pharmacy benefits. Barnes brings a wealth of experience to her new position, having previously held leadership roles at Express Scripts Pharmacy and Rite Aid.
In her new role at GoodRx, Barnes will focus on driving strategic initiatives for the company. This includes plans to incorporate all pharmaceutical companies’ brand affordability programs onto the GoodRx platform, expand product offerings for healthcare professionals, and establish new partnerships with pharmacies, insurers, and drug manufacturers. Her appointment comes after a period of transition for GoodRx, with co-CEOs Trevor Bezdek and Doug Hirsch stepping down in April 2023.
Despite facing challenges such as a decline in stock price and missed investor expectations on earnings and revenue in the third quarter, GoodRx has reported positive financial results. In the third quarter, the company saw an 8% increase in revenue to $195.3 million and posted a net income of $4 million, a significant improvement from the previous year’s loss of $38.5 million.
Barnes’ appointment as CEO marks a new chapter for GoodRx as it continues to navigate the competitive landscape of the healthcare industry. With her leadership and strategic vision, the company is poised to drive growth and innovation in the digital health space.
